Inspire Veterinary Partners, Inc.

IVPR Consumer Cyclical Personal Services

Inspire Veterinary Partners, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $16.6 million, roughly unchanged from fiscal 2023. In the quarter to September 2025, revenue grew 6.60%, EPS grew 51.7% and free cash flow grew 79.1%, each against the same quarter a year earlier.

0.00 0.00 NaN
Market cap
$3.2M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
4/9
Altman Z
−2.68
Beneish M
−4.20
Dividend safety
n/a
Sep '25 Jun '25 Mar '25 Dec '24 Older periods
Piotroski F-Score
4 — — —

+8 more TTM periods

ROE
(337.76%) 983.52% (823.40%) (3,744.37%)
ROA
(52.46%) (61.40%) (61.19%) (69.00%)
ROIC
(53.40%) (60.00%) (53.48%) (59.21%)
Return on Tangible Assets
(1,220.96%) 775.33% (788.48%) (7,011.18%)
Average Days of Receivables
0.67 4.38 0.10 0.90
Free Cash Flow per Share
(0.71) (1.55) (1.50) (1.85)
Free Cash Flow
(4.34) (9.35) (8.31) (10.24)
Capital Expenditures
(0.11) (0.09) (0.10) (0.24)
Other line items
Cash ROIC
(28.31%) (103.19%) (63.82%) (96.86%)
Accounts Receivable Turnover
215.66 136.97 61.88 130.85
Accounts Payable Turnover
6.65 4.45 4.72 5.13
Inventory Turnover
23.65 23.66 24.49 24.44
Average Days of Payables
49.46 55.02 51.69 54.33
Days of Inventory on Hand
14.48 13.99 13.88 14.18
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
69.81% 74.72% 71.39% 68.84%
Share Based Compensation of Revenue
1.05% 1.07% 0.00% 0.00%
Interest Coverage
(4.83) (3.53) (2.77) (2.91)
Operating CF/Net income
0.35 0.71 0.61 0.69
Depreciation/Fixed assets
0.36 0.46 0.60 0.62
Capex/Depreciation
(0.04) (0.03) (0.03) (0.06)
Revenue per Share
2.55 2.54 2.77 2.99
Operating CF per Share
(0.69) (1.54) (1.48) (1.80)
Capex per Share
(0.02) (0.01) (0.02) (0.04)
Capex to Sales
0.01 0.01 0.01 0.01

Fold the line items

Columns are period end dates